News
Boston Scientific Corp. has launched the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System in Japan. This advanced drug-eluting stent (DES) technology system recently received Japan Ministry of Health, Labor and Welfare (MHLW) approval.
May 01, 2014
Technology
Volcano Corp. announced the commencement of its limited market release of its U.S. Food and Drug Administration (FDA) cleared and CE marked technology SyncVision, with cases being performed in the United States and Europe.
May 01, 2014
Feature | Gavin Finn, President and CEO of Kaon Interactive
It is impossible to escape the reality that as the use of mobile electronic devices increases amongst consumers, a proportionate increase in the use of such devices in the medical sales and marketing arena will follow. This is already a significant trend that has spread from pharmaceutical sales to device providers and, indeed, through all aspects of the interaction between physicians and their providers of tools and solutions.
April 30, 2014Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025
Feature | Jen Ireland and Val Kapitula, Ascendian Healthcare Consulting
A successfully implemented CVIS solution allows your organization to modernize and optimize the cardiovascular service line. Breaking down the advantages into terms and next steps you can discuss with your executive suite is essential and will allow you to analyze potential vendorโs offerings and organizational gaps as you move from your legacy environment to the "new vision." Consider the following benefits and features as you develop a comprehensive road map for your future cardiovascular operations and services:
April 30, 2014
News
Imris Inc. announced that a University of South Florida neurosurgical team at Tampa General Hospital (TGH) completed initial cases using its recently installed Visius intraoperative MRI (magnetic resonance imaging) โ providing the most advanced surgery and operating suite in the Tampa Bay area.
April 30, 2014
News
April 30, 2014 โ Fovia Medical Inc. and Imperial College London, a science-based institution in biomedical research, announced a collaboration to bring High Definition Volume Rendering (HDVR) to minimally invasive robotic surgery.
April 30, 2014Sponsored Content
Feature
SPONSORED CONTENT โ Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025
News
National Institutes of Health (NIH) researchers have identified gene variants that cause a rare syndrome of sporadic fevers, skin rashes and recurring strokes, beginning early in childhood.
April 30, 2014
News
Scripps Health became the first health care provider in Southern California to implant the investigational Nanostim leadless pacemaker, the world's first wireless pacemaker totally implanted in the heart, as part of the Leadless II Clinical Trial.
April 30, 2014
Feature
April 30, 2014 โ Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a new ultrasound device that could help identify arterial plaque that is at high risk of breaking off and causing heart attack or stroke.
April 30, 2014Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
April 30, 2014 โ Celladon Corp. announced its lead product candidate, Mydicar, has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA) for reducing hospitalizations for heart failure in NYHA class III or IV chronic heart failure patients who are NAb negative. Celladon is a clinical-stage biotechnology company developing novel therapies for patients with heart failure and other diseases characterized by SERCA enzyme deficiencies.
April 30, 2014News
April 29, 2014 โ Armetheon Inc. announced it has reached agreement with the U.S. Food and Drug Administration (FDA) on a special protocol assessment (SPA) for the final pivotal trial of tecarfarin. Tecarfarin is positioned to be the only oral anticoagulant therapy for patients with prosthetic heart valves (PHV) specifically identified in the label.
April 29, 2014
Technology
Healthcare imaging specialist Barco launched its MDSC-8258, a 58-inch surgical display designed for 4K imaging in hybrid operating rooms and interventional suites.
April 29, 2014Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
John Muir Health announced that its Concord, Calif., medical center is one of the first hospitals in Northern California to implant a miniature cardiac monitor in a patient โ the Reveal Linq Insertable Cardiac Monitor (ICM) System.
April 29, 2014News
When an unmanned supply mission launched into space on April 18, bound for the International Space Station, it meant something extraordinary to Peter Lee, a cardiothoracic surgeon at The Ohio State University Wexner Medical Center. That is because his research experiment is on board.
April 29, 2014News
April 28, 2014 โ JenaValve Technology Inc. โ a privately held, venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation (TAVI) systems โ announced it has secured an expansion to its Series C venture round of $10 million, increasing the total amount raised in the round from $62.5 million to $72.5 million.
April 28, 2014